Stock Taper 
CUTTER CAPITAL MANAGEMENT, LP
Latest 13F filing data - Q1 2025
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Roivant Sciences Ltd. | ROIV | 1.3M | $13.12M |
 Teva Pharmaceutical Industries Limited | TEVA | 801.81K | $12.32M |
 Arcus Biosciences, Inc. | RCUS | 731.82K | $5.74M |
 Perrigo Company plc | PRGO | 479.52K | $13.45M |
| CP CENTESSA PHARMACEUTICALS PLC | CNTA | 418.13K | $6.01M |
 Summit Therapeutics Inc. | SMMT | 400K | $7.72M |
 BridgeBio Pharma, Inc. | BBIO | 390.64K | $13.5M |
 Ultragenyx Pharmaceutical Inc. | RARE | 379.3K | $13.73M |
 Royalty Pharma plc | RPRX | 356.89K | $11.11M |
 Bristol-Myers Squibb Company | BMY | 295K | $17.99M |
 Agios Pharmaceuticals, Inc. | AGIO | 235.35K | $6.9M |
 NewAmsterdam Pharma Company N.V. | NAMS | 221.15K | $4.53M |
 Tarsus Pharmaceuticals, Inc. | TARS | 205K | $10.53M |
 Insmed Incorporated | INSM | 186.38K | $14.22M |
 Cytokinetics, Incorporated | CYTK | 175K | $7.03M |
 Halozyme Therapeutics, Inc. | HALO | 120K | $7.66M |
 Biogen Inc. | BIIB | 113.5K | $15.53M |
 Amgen Inc. | AMGN | 50K | $15.58M |
 Madrigal Pharmaceuticals, Inc. | MDGL | 24K | $7.95M |
 Eli Lilly and Company | LLY | 18K | $14.87M |